Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The increasing incidence rate of hyperuricemia (HUA), a common chronic metabolic disease, seriously threatens public health. Previous studies have shown that rosmarinic acid (RA) has a good effect in lowering uric acid (UA). However, the exact mechanism of RA in treating HUA is still not fully understood.
Purpose: To validate the therapeutic effect of RA on HUA and its potential pharmacological mechanisms through a comprehensive analysis of the gut microbiome, metabolomics and molecular interaction techniques.
Methods: A rat model of HUA was replicated with 10 % fructose water. The therapeutic effect of RA on HUA rats for 28 consecutive days was assessed through histopathology and biochemical analyses. Additionally, 16S rDNA sequencing, metabolomics, molecular docking, molecular dynamics simulation (MDS), surface plasmon resonance (SPR) and microScale thermophoresis (MST) were used to investigate the mechanisms of RA for HUA treatment.
Results: RA could significantly reduce uric acid (UA) levels, inhibit the activities of UA synthase xanthine oxidase (XOD) and adenosine deaminase (ADA), and improve the function of intestinal and renal tissues. Furthermore, RA altered the composition of the gut microbiota in rats by reducing the Firmicutes to Bacteroidota ratio and increasing the abundance of Bacteroides at the genus level. RA could influence the levels of XOD, ADA, and other plasma metabolites. Importantly, RA modulated ABCG2 expression in the intestine and kidney, as well as URAT1 expression in the kidney. MDS proved that RA bound tightly to these transporters, the SRP results indicated that the equilibrium dissociation constants of RA with GLUT9 is 6.20 μM, RA with URAT1 is 667 nM respectively, and the MST results indicated that the equilibrium dissociation constants of RA and ABCG2 is 264.6 nM.
Conclusion: RA can promote UA excretion by regulating the imbalance of gut microbiota and the expressions of URAT1, GLUT9 and ABCGT2 in HUA rats. This study, for the first time, combined gut microbiota, metabolomics and molecular interaction techniques to verify the intrinsic molecular mechanism of RA in the treatment of HUA, providing a basis for the development of UA-lowering drugs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.phymed.2025.157084 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Uncovering the Anti-Atherosclerotic Effect of Isoquercitrin via Microbiome Metabolic Modulation and Network Pharmacology.
J Agric Food Chem
September 2025
College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi 030000, China.
Atherosclerosis (AS) is increasingly recognized as a disease influenced not only by lipid metabolism and inflammation but also by the gut microbiota and their bioactive metabolites. Isoquercitrin (ISO), a natural flavonoid with food-medicine homology, has shown promising antiatherosclerotic potential, yet its underlying mechanisms remain unclear. In this study, ISO administration significantly reduced plaque burden, improved lipid profiles, and restored gut microbial balance by enriching beneficial taxa, such as , , and .
View Article and Find Full Text PDFOmics-driven insights into the molecular pathways driving osteoarthritis pathogenesis.
Connect Tissue Res
September 2025
Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.
Osteoarthritis (OA) is a multifactorial, mechano-inflammatory joint disorder characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling. Despite its high prevalence and significant impact on quality of life, no disease-modifying treatments have been approved. In many other disease areas, advanced omics technologies are impacting the development of advanced therapies.
View Article and Find Full Text PDFMulti-omics reveal developmental stage-specific adaptations of Tropilaelaps mercedesae to the honeybee host.
Insect Sci
September 2025
State Key Laboratory of Resource Insects, Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing, China.
The ectoparasitic honeybee (Apis mellifera) mite Tropilaelaps mercedesae represents a serious threat to Asian apiculture and a growing concern for global beekeeping due to its high reproductive capacity and host adaptability. However, the regulatory mechanisms underlying its host adaptation across life stages remain poorly characterized. Here, we performed integrated transcriptomic, proteomic, and metabolomic analyses of female mites at 4 key postembryonic developmental stages: protonymphs, deutonymphs, mature adults, and reproductive adults.
View Article and Find Full Text PDFExtracellular Vesicles From Schistosoma mansoni Adult Worms Stimulate IL-10 Release by B Cells.
Parasite Immunol
September 2025
Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands.
Schistosome parasites are known to modulate host immune responses, which is achieved in part through the release of excretory/secretory (ES) products, including extracellular vesicles (EVs). During chronic schistosomiasis, increased regulatory responses are found, which include enhanced IL-10 production by B (Breg) cells. ES products from schistosome eggs are able to induce IL-10 production by B cells.
View Article and Find Full Text PDFMechanism of Tetrandrine in Ameliorating Hypoxic Pulmonary Hypertension Vascular Remodeling through Transcriptomics and Metabolomics.
Curr Drug Metab
September 2025
First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 650500, China.
Background: Tetrandrine (TET) demonstrates therapeutic potential for hypoxic pulmonary hypertension (HPH); however, its precise pharmacological mechanisms remain unclear. In this study, we aimed to investigate the effects of TET on pulmonary vascular remodeling (PVR) in HPH and elucidate the molecular pathways through which TET ameliorates HPH.
Methods: We established a rat model of HPH and evaluated the therapeutic effects of TET by measuring hemodynamic parameters, assessing right ventricular hypertrophy, and analyzing pathological changes in lung tissue.